www.medical-devices.tech
18
'26
Written on Modified on
Robotic Surgical Platform Integrates Advanced Bipolar Vessel Sealing
Medtronic secured regulatory clearance to integrate specialized electrosurgical instruments with its robotic platform to support soft-tissue procedures across surgical departments.
www.medtronic.com
Medtronic announced clearance from the U.S. Food and Drug Administration for its Maryland jaw vessel-sealing instrument configured for robotic-assisted surgery. The technology interfaces with the Hugo robotic-assisted surgery system to provide electrosurgical cutting and sealing capabilities during minimally invasive urological and general procedures.
Technical Integration and System Architecture
The instrument is engineered exclusively to interface with the Valleylab FT10 energy platform when operated through the Hugo robotic architecture. This configuration transfers standardized bipolar electrosurgical energy delivery into a multi-arm robotic manipulator interface, standardizing tooling across open, laparoscopic, and robotic operating environments.
Operational Parameters and Tissue Interaction
The end-effector performs bilateral tissue fusion and mechanical division through specific electrosurgical control loops:
- Target structures include blood vessels, lymphatics, and dense tissue bundles measuring up to 7 millimeters in diameter.
- The sealing sequence completes in approximately two seconds under continuous impedance feedback from the generator.
- Energy delivery profiles reduce lateral thermal margin spread to adjacent functional anatomical structures during high-frequency energy application.
Clinical Implementation and Deployment Scope
Initial clinical deployment focuses on urological interventions within domestic operating theaters, following preceding regulatory adoption in Europe under CE Mark verification. The platform addresses structural requirements across soft-tissue disciplines, with expanding protocols aimed at gynecologic and general abdominal indications. By standardizing continuous tissue ligation mechanics across manual and automated instrumentation lines, the system simplifies procedural transitions within existing operating room infrastructure.
Edited by Evgeny Churilov, Induportals Media - Adapted by AI.
www.medtronic.com
Initial clinical deployment focuses on urological interventions within domestic operating theaters, following preceding regulatory adoption in Europe under CE Mark verification. The platform addresses structural requirements across soft-tissue disciplines, with expanding protocols aimed at gynecologic and general abdominal indications. By standardizing continuous tissue ligation mechanics across manual and automated instrumentation lines, the system simplifies procedural transitions within existing operating room infrastructure.
Edited by Evgeny Churilov, Induportals Media - Adapted by AI.
www.medtronic.com
